Parvalbumin, a mitochondrial Ca2+-buffering protein, dramatically lowered ROS production and invasiveness, and suppressed EMT in HCC cells by modulating the Ca2+ flow into mitochondria and rescuing the NAD+/SIRT3/SOD2 axis [246,247]. The gene discussed is PVALB; the disease is hepatocellular carcinoma.